Amino acid metabolism in the brain with convulsive disorders Part 2: The effects of anticonvulsants on convulsions and free amino acid patterns in the brain of El mouse

  • Toshihiro Honda
    Correspondence address: Dr. Toshihiro Honda, Department of Pediatrics, Juntendo University, 3-1-3, Hongo, Bunkyo-ku, Tokyo 113, Japan.
    Department of Pediatrics, Juntendo University School of Medicine, Tokyo
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To elucidate the changes of free amino acid patterns in brains of El mice induced by several anticonvulsants, the free amino acid levels in brains were measured by an amino acid autoanalyzer 24 hours after intraperitoneal injection of PB, PHT or vitamin B6 or subcutaneous injection of ACTH.
      Compared to the preconvulsion group, the total free amino acid level increased in the ACTH group clearly. In the PB group, the levels of threonine, glutamine, lysine, histidine and homocarnosine increased and that of ornithine decreased; in the PHT group, an increase of glutamine and histidine and a decrease of β-alanine and ornithine were observed; in the ACTH group, an increase of aspartic acid, threonine, serine, glutamic acid, glutamine, alanine and GABA and a decrease of cystathionine and ornithine were also observed; and in the vitamin B6 group, an increase of taurine and a decrease of cystathionine were recognized.
      These facts suggest that the sedative activity of these drugs except ACTH might be partially explained by the increase of inhibitory amino acids in the brain, such as glutamine, homocarnosine and taurine, and that of ACTH by the dehydration of the brain, resulting in concentration of many free amino acids.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Honda T. Amino acid metabolism in the brain with convulsive disorders. Part 1. Free amino acid patterns in the brain of El mouse with convulsive seizure. Brain Dev (Tokyo) (in press).

        • Sugiu R
        Pathophysiological study of the epmouse. Part 1. Homocarnosine (γ-aminobutyryl-L-histidine) effect on the ep-mouse (in Japanese).
        Okayama Igakukai Zasshi (Okayama). 1963; 75: 145-159
        • Takahashi H
        • Ohtsuka C
        A case of phenylketonuria with high CSF levels of homocarnosine (in Japanese).
        Nō To Hattatsu (Tokyo). 1981; 13: 67-71
        • Tower DB
        The neurochemistry of asparagine and glutamine.
        in: Brady RO The neurochemistry of nucleosides and amino acids. John Wiley and Sons Inc, New York1960: 173-204
        • Saad SF
        • El-Masry AM
        • Scott PM
        Influence of certain anticonvulsants on the concentration of gamma-aminobutyric acid in the cerebral hemisphere of mice.
        Eur J Pharmacol. 1972; 17: 186-192
        • De Ropp RS
        • Snedeker E
        Effect of drugs on amino acid levels in brain: Excitants and depressants.
        Proc Soc Exp Biol Med. 1961; 106: 696-700
        • Loscher W
        • Frey H-H
        Effect of convulsant and anticonvulsant agents on level and metabolism of γ-aminobutyric acid in mouse brain.
        Arch Pharmacol. 1977; 296: 263-269
        • King LJ
        • Carl JL
        • Lao L
        Brain amino acids during convulsions.
        J Neurochem. 1974; 22: 307-310
        • Perry TL
        • Hansen S
        • Maclean J
        Cerebrospinal fluid and glutamine elevation by anticonvulsant drugs: A potential diagnostic and therapeutic trap.
        Clin Chim Acta. 1976; 69: 441-445
        • Godin Y
        • Heiner L
        • Mark J
        • Mandel P
        Effects of di-n-propylacetate, an anticonvulsive compound, on GABA metabolism.
        J Neurochem. 1969; 16: 869-873
        • Simler S
        • Ciesielski L
        • Maitre M
        • Randrianarisoa H
        • Mandel P
        Effects of sodium n-dipropylacetate on audiogenic seizures and brain γ-aminobutyric acid level.
        Biochem Pharmacol. 1973; 22: 1701-1708
        • Loscher W
        Effect of inhibitors of GABA amino-transferase on the metabolism of GABA in brain tissue and synaptosomal fractions.
        J Neurochem. 1981; 36: 1521-1527
        • Loscher W
        Effects of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.
        J Neurochem. 1980; 34: 1603-1608
        • Anlezark G
        • Horton RW
        • Meldrum BS
        Anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate and the metabolism of gammaaminobutyric acid (GABA) in mice with audiogenic seizures.
        Biochem Pharmacol. 1976; 25: 413-417
        • Whittle SR
        • Turner AJ
        Effects of anticonvulsants on the formation of γ-hydroxybutyrate in rat brain.
        J Neurochem. 1982; 38: 848-851
        • Toggenburger G
        • Felix D
        • Cuénod M
        • Henke H
        In vitro release of endogenous β-alanine, GABA, and glutamate, and electrophysiological effect of β-alanine in pigeon optic tectum.
        J Neurochem. 1982; 39: 176-183
        • Kasahara J
        Experimental study on inhibition of the ep-mouse convulsion. Part 2. Diphenylhydantoin effects on cerebral metabolism of the ep-mouse (in Japanese).
        Okayama Igakukai Zasshi (Okayama). 1962; 74: 573-586
        • Vernadakis A
        • Woodbury DM
        Effects of diphenylhydantoin and adrenocortical steroids on free glutamic acid, glutamine and gamma-aminobutyric acid concentrations of rat cerebral cortex.
        in: Roberts E Inhibition in the nervous system and gamma-aminobutyric acid. Pergamon, Oxford1960: 242-248
        • Bhattacharya S
        • Kishor K
        • Saxenta P
        A neuropharmacological study of gamma-aminobutyric acid (GABA).
        Arch Int Pharmacodyn Ther. 1964; 150: 295-305
        • Sawaya MCB
        • Horton RW
        • Meldrum BS
        Effect of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.
        Epilepsia. 1975; 16: 649-655
        • Bentson J
        • Resa M
        • Winter J
        • Wilson G
        Steroids and apparent atrophy on computed tomography scan.
        J Comt Assist Tomogr. 1978; 2: 16-23
        • Satoh J
        • Takeshige H
        • Hara H
        • Fukuyama Y
        Brain shrinkage and subdural effusion associated with ACTH administration.
        Brain Dev (Tokyo). 1982; 4: 13-20
        • Sato Y
        • Watanabe K
        • Tada H
        • et al.
        The mechanism of brain shrinkage caused by ACTH treatment.
        in: Abstracts of the 3rd International Child Neurology Congress, Copenhagen1982: 84
        • Mutani R
        • Bergamini L
        • Delsedime L
        • Durelli L
        Effects of taurine in chronic experimental epilepsy.
        Brain Res. 1974; 79: 330-332
        • Barbeau A
        • Donaldson J
        Zinc, taurine and epilepsy.
        Arch Neurol. 1974; 30: 52-58
        • Roches J-C
        • Zumstein HR
        • Fässler A
        • Scollo-Lavizzari G
        • Hösli L
        Effects of taurine, glycine and GABA on convulsions produced by strychinine in the rabbit.
        Eur Neurol. 1979; 18: 26-32
        • Roberts E
        • Kuriyama K
        Biochemical physiological correlation in studies of the γ-aminobutyric acid system.
        Brain Res. 1968; 8: 1-35